BEAM THERAPEUTICS INC shareholders Q1 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$134,479,00056.91%
HSG Holding Ltd 796,089$45,616,0005.69%
Redmile Group, LLC 1,836,050$105,206,0003.28%
Deep Track Capital, LP 763,750$43,763,0002.81%
Casdin Capital, LLC 818,820$46,918,0002.10%
ARK Investment Management 8,200,749$469,903,0001.96%
Nan Fung Group Holdings Ltd 54,903$3,146,0001.49%
Evolutionary Tree Capital Management, LLC 34,296$1,965,0001.37%
BRANDYWINE MANAGERS, LLC 13,067$749,0001.29%
Temasek Holdings (Private) Ltd 3,959,212$226,862,8480.96%
FARALLON CAPITAL MANAGEMENT LLC 2,594,387$148,658,0000.72%
Connective Portfolio Management, LLC 5,000$297,0000.64%
Polianta Ltd 16,100$922,0000.60%
Alphabet Inc. 321,604$18,428,0000.60%
Phoenix Wealth Advisors 7,970$437,0000.45%
Neo Ivy Capital Management 8,698$498,0000.45%
Eagle Health Investments LP 28,900$1,656,0000.41%
HighVista Strategies LLC 11,102$636,0000.40%
Cormorant Asset Management, LP 90,045$5,160,0000.40%
Renaissance Capital LLC 15,955$914,0000.39%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q1 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.